En español
NIDA

Menu

Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

Active Healing through the Stage-12 Program & Lifestyle Changes cover

The primary objective of this protocol was to evaluate the degree to which a combined group and individual 12-Step facilitative intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment was usual (TAU) without STAGE-12 among stimulant abusers. For this protocol, STAGE-12 will be integrated into treatment as usual. This was a randomized, 2-group design comparing STAGE-12 integrated into TAU (STAGE-12 /TAU) to TAU without STAGE-12 for stimulant abusers receiving formal substance abuse treatment in participating community-based treatment programs (CTP). A total of approximately 450 stimulant users were recruited from 10 CTPS.

CTN Protocol ID: 
CTN-0031
DSMB ID: 
DSMB-0031
Enrollment Status: 
Completed
ClinicalTrials.gov ID: 
Primary Outcomes Article: 

Donovan, et al. (2012).  Stimulant abuser groups to engage in 12-Step: A multisite trial in the National Institute on Drug Abuse Clinical Trials Network.  Journal of Substance Abuse Treatment.  (Epub ahead of print)
http://www.ncbi.nlm.nih.gov/pubmed?term=22657748

Principal Investigator(s)
Dennis M. Donovan, Ph. D.
Director
University of Washington
Department of Psychiatry and Behavioral Sciences
Alcohol and Drug Abuse Institute
1107 N.E. 45th Street, Suite 120
Box 354805
Seattle, WA 98105
ddonovan@u.washington.edu

Available Brochures

Get this Publication

    Blending Initiative

    blending logo

    Formed with SAMHSA to reduce the gap between research results and treatment.